250 Questions and Answers +Explanation
1. What pharmacokinetic process describes movement of a drug from the site of
administration into systemic circulation?
Answer: Absorption.
Rationale: Absorption is the movement of a drug from its administration site into
the bloodstream. Intravenous drugs bypass the absorption phase because they
enter systemic circulation directly. Factors such as route, blood flow, lipid solubility,
and gastrointestinal motility can influence absorption.
2. Which pharmacokinetic process is primarily responsible for chemical modification
of many drugs?
Answer: Metabolism.
Rationale: Drug metabolism chemically alters medications, frequently making them
more water-soluble for elimination. The liver is the major site of drug metabolism.
Cytochrome P450 enzymes are particularly important in the metabolism of many
medications.
3. What is the primary organ responsible for elimination of most water-soluble
drugs?
Answer: Kidneys.
Rationale: The kidneys eliminate many drugs and metabolites through urine. Renal
impairment can decrease drug clearance and cause accumulation. Dosage
adjustments may therefore be necessary when renal function is reduced.
,4. What does a drug's half-life represent?
Answer: The time required for the plasma concentration of a drug to decrease by
50%.
Rationale: Half-life helps determine dosing intervals and the approximate time
required for a drug to reach steady state. Drugs with longer half-lives remain in the
body longer. Approximately four to five half-lives are generally required to reach
near-steady-state concentrations.
5. What is the pharmacodynamic definition of an agonist?
Answer: A drug that binds to a receptor and activates it.
Rationale: An agonist produces a biological response by activating its target
receptor. Full agonists can produce maximal receptor-mediated effects. Partial
agonists activate receptors but produce a lower maximal response than full
agonists.
6. What is the primary pharmacodynamic action of an antagonist?
Answer: It blocks or reduces the effect of an agonist.
Rationale: An antagonist binds to a receptor without producing the activating
response associated with an agonist. It can prevent endogenous substances or
medications from producing their effects. Competitive antagonists may be displaced
by sufficiently high concentrations of an agonist.
7. Which laboratory value is most important when monitoring warfarin therapy?
Answer: INR.
Rationale: The international normalized ratio measures the anticoagulant effect of
warfarin. The therapeutic INR target depends on the clinical indication, commonly
around 2.0–3.0 for many indications. Excessive INR elevation increases bleeding
risk.
8. Which antidote is used for serious warfarin-associated bleeding?
Answer: Vitamin K.
Rationale: Vitamin K reverses the anticoagulant effect of warfarin by restoring
production of vitamin K-dependent clotting factors. Severe or life-threatening
bleeding may additionally require a factor-replacement product. The urgency of
reversal depends on the severity of bleeding and INR elevation.
9. Which laboratory test is commonly used to monitor unfractionated heparin
,therapy?
Answer: aPTT.
Rationale: Activated partial thromboplastin time is commonly used to monitor
unfractionated heparin. Anti-Xa testing may also be used in some institutions.
Monitoring helps maintain therapeutic anticoagulation while limiting bleeding
complications.
10. What serious adverse effect should be suspected when a patient receiving
heparin develops a substantial platelet decrease?
Answer: Heparin-induced thrombocytopenia.
Rationale: HIT is an immune-mediated reaction associated with platelet activation
and thrombosis. A significant platelet decline, especially several days after
exposure, should raise concern. Heparin should be discontinued and an alternative
non-heparin anticoagulant considered when HIT is suspected.
11. Which medication class is commonly used as first-line therapy for
uncomplicated hypertension?
Answer: Thiazide-type diuretics.
Rationale: Thiazide-type diuretics are effective antihypertensive agents and are
recommended as initial therapy in many patients. Other major first-line options
include ACE inhibitors, ARBs, and calcium channel blockers depending on patient
factors. Selection should account for comorbidities and contraindications.
12. Which electrolyte abnormality is commonly associated with hydrochlorothiazide
therapy?
Answer: Hypokalemia.
Rationale: Thiazide diuretics increase renal sodium delivery to the distal nephron,
promoting potassium excretion. Patients may develop weakness, muscle cramps, or
cardiac rhythm abnormalities if potassium becomes significantly low. Electrolytes
should be monitored during therapy.
13. What major adverse effect should be monitored in a patient taking an ACE
inhibitor?
Answer: Hyperkalemia.
Rationale: ACE inhibitors decrease aldosterone activity, which can reduce potassium
excretion. Hyperkalemia is particularly concerning in patients with renal impairment
or those taking other potassium-raising medications. Serum potassium and renal
function should be monitored.
, 14. Which adverse effect is particularly characteristic of ACE inhibitors?
Answer: Persistent dry cough.
Rationale: ACE inhibition increases bradykinin concentrations, which can contribute
to a persistent nonproductive cough. The cough generally resolves after
discontinuation. An ARB may be considered when continued renin-angiotensin
system blockade is appropriate.
15. Which medication class is generally avoided during pregnancy because of fetal
renal toxicity?
Answer: ACE inhibitors.
Rationale: ACE inhibitors can cause serious fetal injury, particularly later in
pregnancy. Potential complications include impaired fetal renal development and
oligohydramnios. They should be discontinued when pregnancy is recognized and
replaced with an appropriate alternative.
16. Which adverse effect is most associated with amlodipine?
Answer: Peripheral edema.
Rationale: Amlodipine is a dihydropyridine calcium channel blocker that causes
arterial vasodilation. Increased capillary hydrostatic pressure can produce
dependent peripheral edema. The edema is usually not caused by fluid retention
alone.
17. Which medication class can reduce mortality in selected patients with heart
failure with reduced ejection fraction?
Answer: ACE inhibitors.
Rationale: ACE inhibitors reduce maladaptive neurohormonal activation and
decrease afterload. They have demonstrated benefits in appropriately selected
patients with HFrEF. Renal function, potassium, blood pressure, and adverse effects
must be monitored.
18. Which medication is a loop diuretic?
Answer: Furosemide.
Rationale: Furosemide inhibits sodium and chloride reabsorption in the thick
ascending limb of the loop of Henle. It produces potent diuresis and is frequently
used for edema associated with heart failure. Hypokalemia, dehydration,
hypotension, and other electrolyte abnormalities can occur.
1. What pharmacokinetic process describes movement of a drug from the site of
administration into systemic circulation?
Answer: Absorption.
Rationale: Absorption is the movement of a drug from its administration site into
the bloodstream. Intravenous drugs bypass the absorption phase because they
enter systemic circulation directly. Factors such as route, blood flow, lipid solubility,
and gastrointestinal motility can influence absorption.
2. Which pharmacokinetic process is primarily responsible for chemical modification
of many drugs?
Answer: Metabolism.
Rationale: Drug metabolism chemically alters medications, frequently making them
more water-soluble for elimination. The liver is the major site of drug metabolism.
Cytochrome P450 enzymes are particularly important in the metabolism of many
medications.
3. What is the primary organ responsible for elimination of most water-soluble
drugs?
Answer: Kidneys.
Rationale: The kidneys eliminate many drugs and metabolites through urine. Renal
impairment can decrease drug clearance and cause accumulation. Dosage
adjustments may therefore be necessary when renal function is reduced.
,4. What does a drug's half-life represent?
Answer: The time required for the plasma concentration of a drug to decrease by
50%.
Rationale: Half-life helps determine dosing intervals and the approximate time
required for a drug to reach steady state. Drugs with longer half-lives remain in the
body longer. Approximately four to five half-lives are generally required to reach
near-steady-state concentrations.
5. What is the pharmacodynamic definition of an agonist?
Answer: A drug that binds to a receptor and activates it.
Rationale: An agonist produces a biological response by activating its target
receptor. Full agonists can produce maximal receptor-mediated effects. Partial
agonists activate receptors but produce a lower maximal response than full
agonists.
6. What is the primary pharmacodynamic action of an antagonist?
Answer: It blocks or reduces the effect of an agonist.
Rationale: An antagonist binds to a receptor without producing the activating
response associated with an agonist. It can prevent endogenous substances or
medications from producing their effects. Competitive antagonists may be displaced
by sufficiently high concentrations of an agonist.
7. Which laboratory value is most important when monitoring warfarin therapy?
Answer: INR.
Rationale: The international normalized ratio measures the anticoagulant effect of
warfarin. The therapeutic INR target depends on the clinical indication, commonly
around 2.0–3.0 for many indications. Excessive INR elevation increases bleeding
risk.
8. Which antidote is used for serious warfarin-associated bleeding?
Answer: Vitamin K.
Rationale: Vitamin K reverses the anticoagulant effect of warfarin by restoring
production of vitamin K-dependent clotting factors. Severe or life-threatening
bleeding may additionally require a factor-replacement product. The urgency of
reversal depends on the severity of bleeding and INR elevation.
9. Which laboratory test is commonly used to monitor unfractionated heparin
,therapy?
Answer: aPTT.
Rationale: Activated partial thromboplastin time is commonly used to monitor
unfractionated heparin. Anti-Xa testing may also be used in some institutions.
Monitoring helps maintain therapeutic anticoagulation while limiting bleeding
complications.
10. What serious adverse effect should be suspected when a patient receiving
heparin develops a substantial platelet decrease?
Answer: Heparin-induced thrombocytopenia.
Rationale: HIT is an immune-mediated reaction associated with platelet activation
and thrombosis. A significant platelet decline, especially several days after
exposure, should raise concern. Heparin should be discontinued and an alternative
non-heparin anticoagulant considered when HIT is suspected.
11. Which medication class is commonly used as first-line therapy for
uncomplicated hypertension?
Answer: Thiazide-type diuretics.
Rationale: Thiazide-type diuretics are effective antihypertensive agents and are
recommended as initial therapy in many patients. Other major first-line options
include ACE inhibitors, ARBs, and calcium channel blockers depending on patient
factors. Selection should account for comorbidities and contraindications.
12. Which electrolyte abnormality is commonly associated with hydrochlorothiazide
therapy?
Answer: Hypokalemia.
Rationale: Thiazide diuretics increase renal sodium delivery to the distal nephron,
promoting potassium excretion. Patients may develop weakness, muscle cramps, or
cardiac rhythm abnormalities if potassium becomes significantly low. Electrolytes
should be monitored during therapy.
13. What major adverse effect should be monitored in a patient taking an ACE
inhibitor?
Answer: Hyperkalemia.
Rationale: ACE inhibitors decrease aldosterone activity, which can reduce potassium
excretion. Hyperkalemia is particularly concerning in patients with renal impairment
or those taking other potassium-raising medications. Serum potassium and renal
function should be monitored.
, 14. Which adverse effect is particularly characteristic of ACE inhibitors?
Answer: Persistent dry cough.
Rationale: ACE inhibition increases bradykinin concentrations, which can contribute
to a persistent nonproductive cough. The cough generally resolves after
discontinuation. An ARB may be considered when continued renin-angiotensin
system blockade is appropriate.
15. Which medication class is generally avoided during pregnancy because of fetal
renal toxicity?
Answer: ACE inhibitors.
Rationale: ACE inhibitors can cause serious fetal injury, particularly later in
pregnancy. Potential complications include impaired fetal renal development and
oligohydramnios. They should be discontinued when pregnancy is recognized and
replaced with an appropriate alternative.
16. Which adverse effect is most associated with amlodipine?
Answer: Peripheral edema.
Rationale: Amlodipine is a dihydropyridine calcium channel blocker that causes
arterial vasodilation. Increased capillary hydrostatic pressure can produce
dependent peripheral edema. The edema is usually not caused by fluid retention
alone.
17. Which medication class can reduce mortality in selected patients with heart
failure with reduced ejection fraction?
Answer: ACE inhibitors.
Rationale: ACE inhibitors reduce maladaptive neurohormonal activation and
decrease afterload. They have demonstrated benefits in appropriately selected
patients with HFrEF. Renal function, potassium, blood pressure, and adverse effects
must be monitored.
18. Which medication is a loop diuretic?
Answer: Furosemide.
Rationale: Furosemide inhibits sodium and chloride reabsorption in the thick
ascending limb of the loop of Henle. It produces potent diuresis and is frequently
used for edema associated with heart failure. Hypokalemia, dehydration,
hypotension, and other electrolyte abnormalities can occur.
